HWKN trades 14.5% below Wall Street's consensus target of $142.00.
Last 12 months price action with 12-month analyst target path
The base valuation assumes HWKN achieves its forward estimates and maintains a stable P/E multiple of 31.5x. This scenario reflects the blended consensus of 2 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of September 24, 2026, Hawkins, Inc. (HWKN) has a Wall Street consensus price target of $142.00, based on estimates from 2 covering analysts. With the stock currently trading at $123.99, this represents a potential upside of +14.5%. The company has a market capitalization of $2.59B.
Analyst price targets range from a low of $142.00 to a high of $142.00, representing a 0% spread in expectations. The median target of $142.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Buy, with 1 analysts rating the stock as a Buy or Strong Buy,1 rating it Hold, and 0 rating it Sell or Strong Sell. The positive sentiment balance indicates moderate optimism about the stock prospects.
From a valuation perspective, HWKN trades at a trailing P/E of 31.7x and forward P/E of 31.5x. The forward PEG ratio of 2.08 reflects a premium valuation. Analysts expect EPS to grow +1.8% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $80.72, with bear and bull scenarios of $50.86 and $106.36 respectively. Model confidence stands at 47/100, suggesting limited visibility into future performance.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 IOSPInnospec Inc. | $2.4B | $96.60 | $110.00 | +13.9% | Hold | 19.6x | 9 |
 KWRQuaker Houghton | $2.8B | $158.86 | $182.50 | +14.9% | Buy | 20.2x | 15 |
 BCPCBalchem Corp | $5.4B | $168.24 | $215.00 | +27.8% | Buy | 31.1x | 10 |
 CBTCabot Corp. | $4.1B | $78.80 | $94.00 | +19.3% | Buy | 12.4x | 15 |
 TROXTronox Holdings plc | $686M | $4.30 | $8.08 | +87.9% | Buy | — | 17 |
 CCThe Chemours Company | $2.2B | $14.74 | $21.88 | +48.4% | Hold | 14.6x | 20 |
 OLNOlin Corporation | $1.9B | $16.77 | $23.63 | +40.9% | Hold | — | 35 |
 ASIXAdvanSix Inc. | $446M | $16.53 | $30.80 | +86.3% | Buy | 89.4x | 6 |
 NTICNorthern Technologies International Corporation | $75M | $7.86 | — | — | — | — | — |
 LINLinde plc | $217.3B | $469.72 | $563.44 | +20.0% | Buy | 26.3x | 28 |
Quick answers to the most common questions about buying HWKN stock.
Hawkins, Inc. (HWKN) has a consensus 12-month price target of $142, implying 14.5% upside from $123.99. The 2 analysts covering HWKN see moderate appreciation potential.
HWKN has a consensus rating of "Buy" based on 2 Wall Street analysts. The rating breakdown is mixed, with 1 Hold ratings making up the largest segment. The consensus 12-month price target of $142 implies 14.5% upside from current levels.
HWKN trades at a forward P/E of 31.5135x, representing a moderate valuation. With analysts targeting $142 (14.5% implied move), the stock appears reasonably valued with upside.
The most bullish Wall Street analyst has a price target of $142 for HWKN, while the most conservative target is $142. The consensus of $142 represents the median expectation. Our quantitative valuation model projects a bull case target of $106 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
HWKN is lightly followed, with 2 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 1 have Buy ratings, 1 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month HWKN stock forecast based on 2 Wall Street analysts shows a consensus price target of $142, with estimates ranging from $142 (bear case) to $142 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $81, with bear/bull scenarios of $51/$106.
Our quantitative valuation model calculates HWKN's fair value at $81 (base case), with a bear case of $51 and bull case of $106. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 47/100.
HWKN trades at a forward P/E ratio of 31.5x based on next-twelve-months earnings estimates compared to a trailing P/E of 31.7x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Wall Street analysts are optimistic on HWKN, with a "Buy" consensus rating and $142 price target (14.5% upside). 1 of 2 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
HWKN analyst price targets range from $142 to $142, a 0% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $142 consensus represents the middle ground. Our model's $51-$106 range provides an independent fundamental perspective.
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.